NAS:OMCL (USA) Also trade in: Germany

Omnicell Inc

$ 79.81 -1.94 (-2.37%)
Volume: 106,119 Avg Vol (1m): 331,668
Market Cap $: 3.29 Bil Enterprise Value $: 3.31 Bil
P/E (TTM): 85.85 P/B: 4.63
Earnings Power Value 5.84
Net Current Asset Value -0.78
Tangible Book 4.51
Projected FCF 22.34
Median P/S Value 42.74
Graham Number 9.72
Peter Lynch Value 0
DCF (FCF Based) 14.24
DCF (Earnings Based) 26.48
1Y (-%)

Financial Strength : 7/10

GuruFocus Financial Strength Rank measures how strong a company's financial situation is . It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
Current vs industry vs history
Cash-to-Debt 0.80
Cash-To-Debt ranked lower than
80.46% of 2180 companies
in the Health Information Services industry.
Industry Max: 52661, Med: 5.23, Min: 0.01
OMCL: 0.8
Ranked among companies with meaningful Cash-To-Debt only.
Cash-To-Debt range over the past 10 years
Min: 0.04, Med: 10000, Max: 10000
Current: 0.8
0.04
10000
Equity-to-Asset 0.62
Equity-to-Asset ranked higher than
55.70% of 2115 companies
in the Health Information Services industry.
Industry Max: 1.55, Med: 0.6, Min: -56.05
OMCL: 0.62
Ranked among companies with meaningful Equity-to-Asset only.
Equity-to-Asset range over the past 10 years
Min: -0.57, Med: 0.63, Max: 0.78
Current: 0.62
-0.57
0.78
Debt-to-Equity 0.13
Debt-to-Equity ranked higher than
57.93% of 1267 companies
in the Health Information Services industry.
Industry Max: 248.23, Med: 0.27, Min: 0.01
OMCL: 0.13
Ranked among companies with meaningful Debt-to-Equity only.
Debt-to-Equity range over the past 10 years
Min: -0.43, Med: 0.08, Max: 0.59
Current: 0.13
-0.43
0.59
Debt-to-EBITDA 0.88
Debt-to-EBITDA ranked lower than
52.88% of 1112 companies
in the Health Information Services industry.
Industry Max: 5506.28, Med: 1.26, Min: 0.01
OMCL: 0.88
Ranked among companies with meaningful Debt-to-EBITDA only.
Debt-to-EBITDA range over the past 10 years
Min: 0.88, Med: 3.19, Max: 3.35
Current: 0.88
0.88
3.35
Interest Coverage 7.58
Interest Coverage ranked lower than
83.08% of 1702 companies
in the Health Information Services industry.
Industry Max: 14867928, Med: 46.64, Min: 0.01
OMCL: 7.58
Ranked among companies with meaningful Interest Coverage only.
Interest Coverage range over the past 10 years
Min: 1.68, Med: 89.11, Max: 2670.75
Current: 7.58
1.68
2670.75
Piotroski F-Score 6
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 5.73
DISTRESS
GREY
SAFE
Beneish M-Score -2.62
Not Manipulator
Manipulator
WACC vs ROIC %
ROIC 5.9%
WACC 12.85%

Profitability & Growth : 7/10

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.
Current vs industry vs history
Operating Margin % 7.00
Operating Margin ranked higher than
53.26% of 2144 companies
in the Health Information Services industry.
Industry Max: 678.59, Med: 4.91, Min: -510650
OMCL: 7
Ranked among companies with meaningful Operating Margin only.
Operating Margin range over the past 10 years
Min: 0.93, Med: 6.13, Max: 11.25
Current: 7
0.93
11.25
Net Margin % 4.74
Net Margin ranked higher than
55.36% of 2144 companies
in the Health Information Services industry.
Industry Max: 990.53, Med: 3.58, Min: -307550
OMCL: 4.74
Ranked among companies with meaningful Net Margin only.
Net Margin range over the past 10 years
Min: 0.21, Med: 4.54, Max: 6.92
Current: 4.74
0.21
6.92
ROE % 6.00
ROE ranked lower than
50.15% of 2062 companies
in the Health Information Services industry.
Industry Max: 1271.48, Med: 6.36, Min: -234428.57
OMCL: 6
Ranked among companies with meaningful ROE only.
ROE range over the past 10 years
Min: 0.19, Med: 5.8, Max: 8.26
Current: 6
0.19
8.26
ROA % 3.56
ROA ranked higher than
52.57% of 2199 companies
in the Health Information Services industry.
Industry Max: 3269.23, Med: 2.95, Min: -16416.67
OMCL: 3.56
Ranked among companies with meaningful ROA only.
ROA range over the past 10 years
Min: 0.14, Med: 3.37, Max: 5.8
Current: 3.56
0.14
5.8
ROC (Joel Greenblatt) % 31.47
ROC (Joel Greenblatt) ranked higher than
50.44% of 2165 companies
in the Health Information Services industry.
Industry Max: 85250, Med: 23.63, Min: -99999999.99
OMCL: 31.47
Ranked among companies with meaningful ROC (Joel Greenblatt) only.
ROC (Joel Greenblatt) range over the past 10 years
Min: 2.43, Med: 34.44, Max: 64.63
Current: 31.47
2.43
64.63
3-Year Total Revenue Growth Rate 17.60
3-Year Revenue Growth Rate ranked higher than
69.60% of 1829 companies
in the Health Information Services industry.
Industry Max: 1196.4, Med: 6.3, Min: -100
OMCL: 13.7
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
3-Year Revenue Growth Rate range over the past 10 years
Min: -53.3, Med: 11.7, Max: 21.1
Current: 13.7
-53.3
21.1
3-Year Total EBITDA Growth Rate 10.60
3-Year EBITDA Growth Rate ranked lower than
53.72% of 1588 companies
in the Health Information Services industry.
Industry Max: 1165.1, Med: 9.1, Min: -450.9
OMCL: 7
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
3-Year EBITDA Growth Rate range over the past 10 years
Min: 0, Med: 7.55, Max: 130.8
Current: 7
0
130.8
3-Year EPS w/o NRI Growth Rate 3.50
3-Year EPS w/o NRI Growth Rate ranked lower than
60.34% of 1432 companies
in the Health Information Services industry.
Industry Max: 719.3, Med: 10.7, Min: -502.1
OMCL: 3.5
Ranked among companies with meaningful 3-Year EPS w/o NRI Growth Rate only.
3-Year EPS w/o NRI Growth Rate range over the past 10 years
Min: 0, Med: 0.95, Max: 260.9
Current: 3.5
0
260.9

» OMCL's 30-Y Financials

Financials (Next Earnings Date: 2019-07-26)

Guru Trades Click for details

» Details

Insider Trades

SEC Filings

Gurus Latest Trades with NAS:OMCL

» Interactive Chart

Peter Lynch Chart

Business Description

Industry Application Software » Health Information Services    NAICS : 621999    SIC : 8099
Compare XTER:COP SZSE:300253 NAS:CVET NYSE:TDOC NAS:PINC NAS:INOV NAS:HQY SZSE:300451 ASX:PME HKSE:02666 NAS:NXGN NAS:RCM NAS:TRHC NYSE:EVH XPAR:PHA LSE:CRW LSE:EMIS HKSE:01833 NAS:MDSO SZSE:300288
Traded in other countries OC9.Germany
Address 590 East Middlefield Road, Mountain View, CA, USA, 94043
Omnicell provides automation and business analytics software for healthcare providers. The firm operates in two segments: automation and analytics and medication adherence. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. This segment contributes the majority of revenue. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States.

Ratios

Current vs industry vs history
PE Ratio (TTM) 85.85
PE Ratio ranked lower than
87.25% of 1475 companies
in the Health Information Services industry.
Industry Max: 10600, Med: 24.79, Min: 0.01
OMCL: 85.85
Ranked among companies with meaningful PE Ratio only.
PE Ratio range over the past 10 years
Min: 13.73, Med: 45.86, Max: 2757.14
Current: 85.85
13.73
2757.14
Forward PE Ratio 31.65
Forward P/E ranked lower than
60.09% of 456 companies
in the Health Information Services industry.
Industry Max: 2500, Med: 26.18, Min: 2.66
OMCL: 31.65
Ranked among companies with meaningful Forward P/E only.
N/A
PE Ratio without NRI 85.85
PE without NRI ranked lower than
88.19% of 1414 companies
in the Health Information Services industry.
Industry Max: 10600, Med: 24.46, Min: 0.01
OMCL: 85.85
Ranked among companies with meaningful PE without NRI only.
PE without NRI range over the past 10 years
Min: 13.73, Med: 45.86, Max: 2757.14
Current: 85.85
13.73
2757.14
Price-to-Owner-Earnings 72.20
Price-to-Owner-Earnings ranked lower than
76.63% of 826 companies
in the Health Information Services industry.
Industry Max: 2445, Med: 25.26, Min: 0.08
OMCL: 72.2
Ranked among companies with meaningful Price-to-Owner-Earnings only.
Price-to-Owner-Earnings range over the past 10 years
Min: 7.6, Med: 45.71, Max: 804.48
Current: 72.2
7.6
804.48
PB Ratio 4.63
PB Ratio ranked lower than
66.93% of 2262 companies
in the Health Information Services industry.
Industry Max: 5500, Med: 2.93, Min: 0.01
OMCL: 4.63
Ranked among companies with meaningful PB Ratio only.
PB Ratio range over the past 10 years
Min: 0.96, Med: 2.41, Max: 5.03
Current: 4.63
0.96
5.03
PS Ratio 4.07
PS Ratio ranked lower than
64.59% of 2268 companies
in the Health Information Services industry.
Industry Max: 285714.29, Med: 2.86, Min: 0
OMCL: 4.07
Ranked among companies with meaningful PS Ratio only.
PS Ratio range over the past 10 years
Min: 0.94, Med: 2.18, Max: 4.44
Current: 4.07
0.94
4.44
Price-to-Free-Cash-Flow 59.97
Price-to-Free-Cash-Flow ranked lower than
65.26% of 924 companies
in the Health Information Services industry.
Industry Max: 2237.2, Med: 28.2, Min: 0.08
OMCL: 59.97
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
Price-to-Free-Cash-Flow range over the past 10 years
Min: 8.02, Med: 38.81, Max: 351.05
Current: 59.97
8.02
351.05
Price-to-Operating-Cash-Flow 29.51
Price-to-Operating-Cash-Flow ranked lower than
65.03% of 1181 companies
in the Health Information Services industry.
Industry Max: 6271.25, Med: 20.26, Min: 0.04
OMCL: 29.51
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
Price-to-Operating-Cash-Flow range over the past 10 years
Min: 6.98, Med: 21.46, Max: 10100
Current: 29.51
6.98
10100
EV-to-EBIT 58.55
EV-to-EBIT ranked lower than
86.34% of 1537 companies
in the Health Information Services industry.
Industry Max: 119475.88, Med: 18.1, Min: 0.05
OMCL: 58.55
Ranked among companies with meaningful EV-to-EBIT only.
EV-to-EBIT range over the past 10 years
Min: 5.3, Med: 26.4, Max: 879.4
Current: 58.55
5.3
879.4
EV-to-EBITDA 29.87
EV-to-EBITDA ranked lower than
76.64% of 1661 companies
in the Health Information Services industry.
Industry Max: 64649.64, Med: 14.06, Min: 0.01
OMCL: 29.87
Ranked among companies with meaningful EV-to-EBITDA only.
EV-to-EBITDA range over the past 10 years
Min: 3.7, Med: 15.9, Max: 38.9
Current: 29.87
3.7
38.9
EV-to-Revenue 4.10
EV-to-Revenue ranked lower than
63.52% of 2327 companies
in the Health Information Services industry.
Industry Max: 295554.27, Med: 2.52, Min: 0.01
OMCL: 4.1
Ranked among companies with meaningful EV-to-Revenue only.
EV-to-Revenue range over the past 10 years
Min: 0.4, Med: 2, Max: 4.6
Current: 4.1
0.4
4.6
PEG Ratio 15.41
PEG Ratio ranked lower than
96.15% of 650 companies
in the Health Information Services industry.
Industry Max: 288.5, Med: 1.89, Min: 0.02
OMCL: 15.41
Ranked among companies with meaningful PEG Ratio only.
PEG Ratio range over the past 10 years
Min: 0.5, Med: 3.05, Max: 358.8
Current: 15.41
0.5
358.8
Shiller PE Ratio 150.76
Shiller PE Ratio ranked lower than
93.54% of 588 companies
in the Health Information Services industry.
Industry Max: 13256.8, Med: 33.85, Min: 0.02
OMCL: 150.76
Ranked among companies with meaningful Shiller PE Ratio only.
Shiller PE Ratio range over the past 10 years
Min: 36.8, Med: 61.22, Max: 172.38
Current: 150.76
36.8
172.38
Current Ratio 1.96
Current Ratio ranked higher than
50.55% of 2075 companies
in the Health Information Services industry.
Industry Max: 672.73, Med: 1.93, Min: 0.01
OMCL: 1.96
Ranked among companies with meaningful Current Ratio only.
Current Ratio range over the past 10 years
Min: 0.64, Med: 2.12, Max: 5.21
Current: 1.96
0.64
5.21
Quick Ratio 1.47
Quick Ratio ranked lower than
60.24% of 2075 companies
in the Health Information Services industry.
Industry Max: 672.73, Med: 1.78, Min: 0.01
OMCL: 1.47
Ranked among companies with meaningful Quick Ratio only.
Quick Ratio range over the past 10 years
Min: 0.4, Med: 1.78, Max: 4.95
Current: 1.47
0.4
4.95
Days Inventory 88.53
Days Inventory ranked lower than
83.23% of 1270 companies
in the Health Information Services industry.
Industry Max: 73152.82, Med: 16.77, Min: 0.01
OMCL: 88.53
Ranked among companies with meaningful Days Inventory only.
Days Inventory range over the past 10 years
Min: 35.43, Med: 56.55, Max: 88.53
Current: 88.53
35.43
88.53
Days Sales Outstanding 92.01
Days Sales Outstanding ranked lower than
69.02% of 2082 companies
in the Health Information Services industry.
Industry Max: 989.79, Med: 66.86, Min: 0.02
OMCL: 92.01
Ranked among companies with meaningful Days Sales Outstanding only.
Days Sales Outstanding range over the past 10 years
Min: 56.2, Med: 69.97, Max: 97.33
Current: 92.01
56.2
97.33
Days Payable 33.41
Days Payable ranked lower than
60.75% of 1870 companies
in the Health Information Services industry.
Industry Max: 2567.37, Med: 44.89, Min: 0.02
OMCL: 33.41
Ranked among companies with meaningful Days Payable only.
Days Payable range over the past 10 years
Min: 26.08, Med: 34.86, Max: 46.45
Current: 33.41
26.08
46.45

Dividend & Buy Back

Current vs industry vs history
3-Year Share Buyback Rate -3.60
3-Year Share Buyback Rate ranked lower than
51.56% of 1507 companies
in the Health Information Services industry.
Industry Max: 100, Med: -3.3, Min: -1487.4
OMCL: -3.6
Ranked among companies with meaningful 3-Year Share Buyback Rate only.
3-Year Share Buyback Rate range over the past 10 years
Min: -140.8, Med: -3.1, Max: 1.6
Current: -3.6
-140.8
1.6

Valuation & Return

Current vs industry vs history
Price-to-Tangible-Book 17.70
Price-to-Tangible-Book ranked lower than
81.62% of 2013 companies
in the Health Information Services industry.
Industry Max: 5500, Med: 4.54, Min: 0.01
OMCL: 17.7
Ranked among companies with meaningful Price-to-Tangible-Book only.
Price-to-Tangible-Book range over the past 10 years
Min: 1.2, Med: 5.64, Max: 188.72
Current: 17.7
1.2
188.72
Price-to-Projected-FCF 3.57
Price-to-Intrinsic-Value-Projected-FCF ranked lower than
67.48% of 907 companies
in the Health Information Services industry.
Industry Max: 650.5, Med: 2.08, Min: 0.01
OMCL: 3.57
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
Price-to-Intrinsic-Value-Projected-FCF range over the past 10 years
Min: 0.94, Med: 1.66, Max: 12.74
Current: 3.57
0.94
12.74
Price-to-DCF (Earnings Based) 3.01
Price-to-Intrinsic-Value-DCF (Earnings Based) ranked lower than
87.63% of 186 companies
in the Health Information Services industry.
Industry Max: 52.79, Med: 1.56, Min: 0.13
OMCL: 3.01
Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only.
Price-to-Intrinsic-Value-DCF (Earnings Based) range over the past 10 years
Min: 3.3, Med: 3.95, Max: 226
Current: 3.01
3.3
226
Price-to-Median-PS-Value 1.87
Price-to-Median-PS-Value ranked lower than
87.92% of 2062 companies
in the Health Information Services industry.
Industry Max: 78, Med: 1, Min: 0.02
OMCL: 1.87
Ranked among companies with meaningful Price-to-Median-PS-Value only.
Price-to-Median-PS-Value range over the past 10 years
Min: 0.23, Med: 1.05, Max: 2.25
Current: 1.87
0.23
2.25
Price-to-Graham-Number 8.21
Price-to-Graham-Number ranked lower than
89.23% of 1170 companies
in the Health Information Services industry.
Industry Max: 84.5, Med: 2.19, Min: 0.01
OMCL: 8.21
Ranked among companies with meaningful Price-to-Graham-Number only.
Price-to-Graham-Number range over the past 10 years
Min: 1.33, Med: 3.23, Max: 26.22
Current: 8.21
1.33
26.22
Earnings Yield (Joel Greenblatt) % 1.71
Earnings Yield (Greenblatt) ranked lower than
54.66% of 2413 companies
in the Health Information Services industry.
Industry Max: 2103.44, Med: 2.07, Min: -5000
OMCL: 1.71
Ranked among companies with meaningful Earnings Yield (Greenblatt) only.
Earnings Yield (Greenblatt) range over the past 10 years
Min: 0.1, Med: 3.8, Max: 19
Current: 1.71
0.1
19
Forward Rate of Return (Yacktman) % 4.90
Forward Rate of Return ranked lower than
70.18% of 939 companies
in the Health Information Services industry.
Industry Max: 34548.51, Med: 10.12, Min: -301.2
OMCL: 4.9
Ranked among companies with meaningful Forward Rate of Return only.
Forward Rate of Return range over the past 10 years
Min: 0.8, Med: 21.6, Max: 25
Current: 4.9
0.8
25

More Statistics

Revenue (TTM) (Mil) $ 807.21
EPS (TTM) $ 0.93
Beta 1.68
Volatility % 43.54
52-Week Range $ 45.15 - 86.87
Shares Outstanding (Mil) 41.22

Analyst Estimate

Piotroski F-Score Details

Piotroski F-Score 6
Positive ROA Y
Positive CFROA Y
Higher ROA yoy N
CFROA > ROA Y
Lower Leverage yoy Y
Higher Current Ratio yoy Y
Less Shares Outstanding yoy N
Higher Gross Margin yoy Y
Higher Asset Turnover yoy N